The University of Southampton
University of Southampton Institutional Repository

Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years

Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years
Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years
The highest incidence rate of childhood brain tumours is in children below the age of five years, who are particularly vulnerable to the effects of treatments. The assessment of quality of survival (QoS) in multiple domains is essential to compare the outcomes for different tumour types and treatment regimens.

The aim of this position statement is to present the domains of health and functioning to be assessed in children from birth to five years, to advance the collection of a common QoS data set in European brain tumour trials.

The QoS group of the European Society of Paediatric Oncology (SIOP-E) Brain Tumour group conducted consensus discussions over a period of six years to establish domains of QoS that should be prioritised in clinical trials involving children under 5 years.

The domains of health and functioning that were agreed to affect QoS included: medical outcomes (e.g. vision, hearing, mobility, endocrine), emotion, behaviour, adaptive behaviour, and cognitive functioning.

As for children aged five years and older, a ‘core plus’ approach is suggested in which core assessments are recommended for all clinical trials. The core component for children from birth to three years includes indirect assessment which, in this age-group, requires proxy assessment by a parent, of cognitive, emotional and behaviour variables and both direct and indirect endocrine measures. For children from four years of age direct cognitive assessment is also recommended as ‘core’. The ‘plus’ components enable the addition of assessments which can be selected by individual countries and/or by, age-, treatment-, tumour type- and tumour location- specific trials.
Assessment, Brain tumor, Infants, Late effects, Quality of survival, Young children
1351-5101
59-67
Limond, J.
dd1f37dc-5ea4-48df-83a4-71a43edfb9ab
Thomas, S.
0f83004b-179e-4b71-8374-25345d0e9dad
Bull, Kim
751f8b25-29ba-4d4f-96e2-6c339a83a47f
Calaminus, G.
5f85276d-ee2b-4336-8b0b-a94c7b69c7b2
Lemiere, J.
b889059c-b463-48ef-8fc7-04169b15be5c
Traunwieser, T.
a35a5ab5-770c-420f-8006-4fb6a6de31be
Van Santen, H.M.
f8622afc-ecdd-4648-bed2-644d60006fea
Weiler, L.
c63234a6-c358-4124-9b5d-2c882907e846
Spoudeas, H.A.
14125f12-6f5e-4592-8437-528ce7cc92db
Chevignard, M.
4bc19521-5c91-44cd-a4ca-20197d744e7a
Limond, J.
dd1f37dc-5ea4-48df-83a4-71a43edfb9ab
Thomas, S.
0f83004b-179e-4b71-8374-25345d0e9dad
Bull, Kim
751f8b25-29ba-4d4f-96e2-6c339a83a47f
Calaminus, G.
5f85276d-ee2b-4336-8b0b-a94c7b69c7b2
Lemiere, J.
b889059c-b463-48ef-8fc7-04169b15be5c
Traunwieser, T.
a35a5ab5-770c-420f-8006-4fb6a6de31be
Van Santen, H.M.
f8622afc-ecdd-4648-bed2-644d60006fea
Weiler, L.
c63234a6-c358-4124-9b5d-2c882907e846
Spoudeas, H.A.
14125f12-6f5e-4592-8437-528ce7cc92db
Chevignard, M.
4bc19521-5c91-44cd-a4ca-20197d744e7a

Limond, J., Thomas, S., Bull, Kim, Calaminus, G., Lemiere, J., Traunwieser, T., Van Santen, H.M., Weiler, L., Spoudeas, H.A. and Chevignard, M. (2020) Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years. European Journal of Neurology, 25, 59-67. (doi:10.1016/j.ejpn.2019.10.002).

Record type: Article

Abstract

The highest incidence rate of childhood brain tumours is in children below the age of five years, who are particularly vulnerable to the effects of treatments. The assessment of quality of survival (QoS) in multiple domains is essential to compare the outcomes for different tumour types and treatment regimens.

The aim of this position statement is to present the domains of health and functioning to be assessed in children from birth to five years, to advance the collection of a common QoS data set in European brain tumour trials.

The QoS group of the European Society of Paediatric Oncology (SIOP-E) Brain Tumour group conducted consensus discussions over a period of six years to establish domains of QoS that should be prioritised in clinical trials involving children under 5 years.

The domains of health and functioning that were agreed to affect QoS included: medical outcomes (e.g. vision, hearing, mobility, endocrine), emotion, behaviour, adaptive behaviour, and cognitive functioning.

As for children aged five years and older, a ‘core plus’ approach is suggested in which core assessments are recommended for all clinical trials. The core component for children from birth to three years includes indirect assessment which, in this age-group, requires proxy assessment by a parent, of cognitive, emotional and behaviour variables and both direct and indirect endocrine measures. For children from four years of age direct cognitive assessment is also recommended as ‘core’. The ‘plus’ components enable the addition of assessments which can be selected by individual countries and/or by, age-, treatment-, tumour type- and tumour location- specific trials.

Text
QOS under 5 years version for resubmission 021019 - Accepted Manuscript
Download (77kB)

More information

Accepted/In Press date: 14 October 2019
e-pub ahead of print date: 25 October 2019
Published date: 1 April 2020
Additional Information: Note: the author list for this article was displaying incorectly in the citation for an unknown period.
Keywords: Assessment, Brain tumor, Infants, Late effects, Quality of survival, Young children

Identifiers

Local EPrints ID: 435172
URI: http://eprints.soton.ac.uk/id/eprint/435172
ISSN: 1351-5101
PURE UUID: 72f3f3c2-67bf-40c0-93b2-abff6b8a1e04
ORCID for Kim Bull: ORCID iD orcid.org/0000-0002-5541-4556

Catalogue record

Date deposited: 25 Oct 2019 16:30
Last modified: 17 Mar 2024 02:48

Export record

Altmetrics

Contributors

Author: J. Limond
Author: S. Thomas
Author: Kim Bull ORCID iD
Author: G. Calaminus
Author: J. Lemiere
Author: T. Traunwieser
Author: H.M. Van Santen
Author: L. Weiler
Author: H.A. Spoudeas
Author: M. Chevignard

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×